GABA and glutamate are two of the main neurotransmitters in the mammalian brain. Both substances can activate both ionotropic receptors (GABA A receptors and NMDA, AMPA, and kainate glutamate receptors) and metabotropic receptors (GABA B and a multiplicity of subtypes of metabotropic glutamate receptors), located both pre-and postsynaptically. This creates conditions in which mutual modulation of these receptors could occur [1,39].Postsynaptic GABA B receptors are present in the rat cerebral cortex [34], are coupled with G-proteins of the Gi/o type, and their activation can lead to various intracellular reactions, the main of which are a decrease in adenylate cyclase activity and a resultant reduction in protein kinase A activity [7,15,30]. Activation of this intracellular cascade leads to various changes in the activity of intracellular signal molecules [15,19]. The effects of activation of GABA B receptors may include modulation of ionotropic receptors, as many of these have sites for intracellular signal molecules. Thus, the intracellular domains of various GABA A receptor subunits have sites specifi c for protein kinases A, C, and G, calcium/calmodulin-dependent kinase Cam KII, and tyrosine kinases [9, 17, 18, 22-28, 35, 45, 46].There are presently several lines of evidence for modulation of the various ionotropic receptors via GABA B receptors. Baclofen, a GABA B receptor agonist, has been demonstrated to produce an irreversible decrease in the amplitude of the current induced by application of glycine in frog spinal cord neurons [3].Patch clamp experiments with fi xation of the membrane potential were performed on isolated rat prefrontal cortex neurons to study the modulation of ion currents induced by applications of GABA and kainate by GABA B receptors and group I metabotropic glutamate receptors. Blockade of GABA B receptors with the selective antagonist CGP-55845 (5 μM) increased the peak amplitude of the ion current induced by application of GABA (40 μM) by 26 ± 13% (n = 6). The amplitude of the ion current plateau at 14 sec of application of GABA was the same in controls as with blockade of GABA B receptors. The long-term effects of activation of GABA B receptors were studied in terms of the responses to application of GABA and kainate in the presence of baclofen (50 μM), a selective GABA B receptor agonist. Prolonged prior application of baclofen increased the amplitude of responses to application of GABA by 9 ± 2% (n = 8) as compared with controls. Responses to application of kainate did not change in the presence of baclofen. Analogous experiments using trans-ACPD, a selective agonist of groups I and II metabotropic glutamate receptors, did not reveal any changes in responses to application of GABA or kainate. These data point to modulation of GABA A receptors by postsynaptic metabotropic GABA B receptors in rat cerebral cortex neurons.